2.1 Common Elements for Hospitals (continued)
b. USP <797>: Pharmaceutical Compounding—Sterile Preparations c. USP <800>: Hazardous Drugs—Handling in Healthcare Settings (1) A room or area for receiving, unpacking, and inventory control of materials used in the pharmacy (2) Work counters and space for automated and manual dispensing activities (3) An extemporaneous compounding area.
Download 2.1 Common Elements for Hospitals (continued)
Information
Domain:
Source:
Link to this page:
Documents from same domain
Recommended Standards for Newborn ICU Design
fgiguidelines.orgAAP/ACOG’s Guidelines for Perinatal Care, and standards documents in several other 1Committee on Perinatal Health, Toward Improving the Outcome of Pregnancy: Recommendations for the Regional Development of Maternal and Perinatal Services (White Plains, N.Y.: The National Foundation–March of Dimes, 1976).
Related documents
Disclaimer for Compliance with USP an Assessment of Risk
www.ashpmedia.orgDesign for Nonsterile Compounding Primary Engineering Control • Containment Ventilated Enclosure (“powder hood”) Secondary Engineering Control
USP 797 Compliance in the Laminar Flow Workstation
www.airscience.comCabinet Design Attributes and Best Practices Chambre, Andre: CEO, Air Science LLC October 2016 Introduction Regulatory compliance procedures abound for the pharmaceutical industry, but perhaps one of the best-known in the compounding side of the industry is USP 797, Sterile Pharmaceutical Compounding Procedures. USP 797 compliance focuses on
Chapter 21-4.1.0 - Design Requirements for Compounded ...
www.ihs.govdefined in USP 797-2008, the buffer room shall be ... The rooms used for compounding sterile and hazardous drug preparations shall comply with the design recommendations ... Chapter 21-4.1.0 - Design Requirements for Compounded Sterile and Hazardous Drug Preparation Areas ...
BRIEFING 797 Pharmaceutical Compounding—Sterile ...
www.usp.orgBRIEFING 〈797〉 Pharmaceutical Compounding—Sterile Preparations, USP 41 page 6554 and PF 41(6) [Nov.–Dec. 2015]. Based on the number and significance of public comments received in response to the revision proposal published in PF 41(6), the USP Compounding Expert Committee is proposing to revise this chapter.